These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 11166911)
21. Comparative ability of ibuprofen and N-(4-hydroxyphenyl)retinamide to inhibit development of rat mammary adenocarcinomas associated with differential inhibition of gene expression of cyclooxygenase isoforms. Parrett ML; Abou-Issa HM; Alshafie G; Ross MS; Harris RE; Robertson FM Anticancer Res; 1999; 19(6B):5079-85. PubMed ID: 10697514 [TBL] [Abstract][Full Text] [Related]
22. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor. Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065 [TBL] [Abstract][Full Text] [Related]
23. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells. Liu CY; Lai YY; Lo CJ J Surg Res; 2004 Apr; 117(2):223-31. PubMed ID: 15047127 [TBL] [Abstract][Full Text] [Related]
24. Cholinergic receptor up-regulates COX-2 expression and prostaglandin E(2) production in colon cancer cells. Yang WL; Frucht H Carcinogenesis; 2000 Oct; 21(10):1789-93. PubMed ID: 11023534 [TBL] [Abstract][Full Text] [Related]
25. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Sheikh MS; Shao ZM; Li XS; Ordonez JV; Conley BA; Wu S; Dawson MI; Han QX; Chao WR; Quick T Carcinogenesis; 1995 Oct; 16(10):2477-86. PubMed ID: 7586155 [TBL] [Abstract][Full Text] [Related]
26. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772 [TBL] [Abstract][Full Text] [Related]
27. Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s). Narayanan BA; Condon MS; Bosland MC; Narayanan NK; Reddy BS Clin Cancer Res; 2003 Aug; 9(9):3503-13. PubMed ID: 12960143 [TBL] [Abstract][Full Text] [Related]
29. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477 [TBL] [Abstract][Full Text] [Related]
30. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study]. Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595 [TBL] [Abstract][Full Text] [Related]
31. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products. Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53. Swamy MV; Herzog CR; Rao CV Cancer Res; 2003 Sep; 63(17):5239-42. PubMed ID: 14500353 [TBL] [Abstract][Full Text] [Related]
33. Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor. Moalic S; Liagre B; Le Bail JC; Beneytout JL Int J Oncol; 2001 Mar; 18(3):533-40. PubMed ID: 11179483 [TBL] [Abstract][Full Text] [Related]
34. Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines. Wu GS; Zou SQ; Liu ZR; Tang ZH; Wang JH World J Gastroenterol; 2003 Jun; 9(6):1302-6. PubMed ID: 12800245 [TBL] [Abstract][Full Text] [Related]
35. Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells. Shan D; Gopal AK; Press OW Clin Cancer Res; 2001 Aug; 7(8):2490-5. PubMed ID: 11489831 [TBL] [Abstract][Full Text] [Related]
36. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines. Kazmi SM; Plante RK; Visconti V; Lau CY Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761 [TBL] [Abstract][Full Text] [Related]
37. The effect of cyclooxygenase inhibitor diclofenac on experimental murine colon carcinoma. Falkowski M; Skogstad S; Shahzidi S; Smedsröd B; Sveinbjörnsson B Anticancer Res; 2003; 23(3B):2303-8. PubMed ID: 12894507 [TBL] [Abstract][Full Text] [Related]
38. p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action. Takahashi N; Watanabe Y; Maitani Y; Yamauchi T; Higashiyama K; Ohba T Int J Cancer; 2008 Feb; 122(3):689-98. PubMed ID: 17955489 [TBL] [Abstract][Full Text] [Related]
39. Antiproliferative effects of nitrosulindac on human colon adenocarcinoma cell lines. Lavagna C; Burgaud JL; Del Soldato P; Rampal P Biochem Biophys Res Commun; 2001 Jun; 284(3):808-16. PubMed ID: 11396974 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide. Jinno H; Steiner MG; Mehta RG; Osborne MP; Telang NT Carcinogenesis; 1999 Feb; 20(2):229-36. PubMed ID: 10069458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]